Memantine

A medication used to manage moderate to severe Alzheimer’s disease symptoms

Breakthrough Drug Offers New Hope for Advanced Alzheimer’s
Memantine shown to be effective against the later stages of Alzheimer's offers new hope for treating the illness at a time when patients and caregivers need it most.
Drug for Late Alzheimer’s Moves Closer to Approval
Memanatine (brand name Namenda) may offer a new option for the later stages of Alzheimer's disease.
New Drug, Alzhemed, Shows Early Promise Against Alzheimer’s
Namenda, the first drug shown to have benefits against moderate to severe Alzheimer's, approved for U.S. sale.
Study of New Alzheimer’s Drug, Namenda, Expands
Scientists continue to examine the possible benefits of Namenda (memantine), approved for later-stage disease.
Drug Cocktail May Slow Alzheimer’s
Memantine is marketed for moderate-to-severe Alzheimer's, but two recent studies suggest it is effective for all stages of the disease when used in combination with any one of the older Alzheimer's drugs.